Ampio Pharmaceuticals, Inc. AMPE
Set alert
0.18 USD 0.00 0.00%
At close · Oct 30
0.0052 Day range 0.0052
0.0052 52-week range 0.6435
- YTD
- +3,421.15%
- 1 year
- +3,421.15%
- Open
- 0.0052
- Prev close
- 0.1831
- Mkt cap
- 207.88K
- Vol
- 334
- Avg vol
- 0
- EPS
- -722.91
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.0052
- High
- 0.0052
- Forward P/E
- -3.39
- Beta
- 1.95
- Short ratio
- 0.31
- Inst. own
- 4.19%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Dec 24, 2024
- 50-d avg
- 1.49
- 200-d avg
- 2.82
- 1y target
- 0.00
6M chart
Signals (13)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Sep 30, 2026 | 1 month ago |
| SMA: Bearish | Sep 25, 2026 | 1 month ago |
| SMA: Bullish | Jul 27, 2026 | 3 months ago |
| SMA: Bullish | Jul 21, 2026 | 3 months ago |
| SMA: Bearish | Jul 16, 2026 | 3 months ago |
| SMA: Bearish | Jul 10, 2026 | 3 months ago |
| MACD: Sell Signal | Jun 2, 2026 | 5 months ago |
| SMA: Bullish | May 13, 2026 | 5 months ago |
| SMA: Bearish | May 8, 2026 | 5 months ago |
| SMA: Bullish | May 7, 2026 | 5 months ago |
| SMA: Bullish | May 7, 2026 | 5 months ago |
| MACD: Buy Signal | May 7, 2026 | 5 months ago |
| RSI: Overbought | May 7, 2026 | 5 months ago |
Key statistics
- Market cap
- 346.28K
- Enterprise value
- -2.97M
- Trailing P/E
- 0.00
- Forward P/E
- -3.39
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.08
- EPS (TTM)
- -10.66
- Beta
- 1.95
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 0
- Revenue growth
- 0.00%
- Free cash flow
- -5.37M
- Total cash
- 4.12M
- Total debt
- 451.00K
- Return on equity
- -113.96%
- Shares outstanding
- 1.14M
- Short % of float
- 2.94%
- 50-day average
- 1.49
- 200-day average
- 2.82
Analyst view
Consensus: hold
Hold
Price target (mean) 0.00
Next earnings
Dec 24, 2024
Expected Dec 24, 2024. Consensus EPS estimate 0.00.
Financials — quick view
AMPE Revenue — quarterly 0
AMPE Net income — quarterly -2.05M
AMPE EPS — quarterly -2.48
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Dec 24, 2024 | Sep 1, 2024 | 0.00 | — | — | — |
| Oct 1, 2024 | Jun 1, 2024 | 0.00 | — | — | — |
| Jul 1, 2024 | Mar 1, 2024 | 0.00 | — | — | — |
| Mar 27, 2024 | Dec 1, 2023 | 0.00 | -2.48 | — | — |
| Nov 14, 2023 | Sep 1, 2023 | 0.00 | -1.53 | — | — |
| Aug 8, 2023 | Jun 1, 2023 | 0.00 | -1.80 | — | — |
About Ampio Pharmaceuticals, Inc.
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- ampiopharma.com
News
- Head to Head Comparison: Ampio Pharmaceuticals (NYSE:AMPE) & Vincerx Pharma (NASDAQ:VINC)
- Critical Contrast: Ampio Pharmaceuticals (NYSE:AMPE) vs. Trevena (NASDAQ:TRVN)
- Ampio Pharmaceuticals (NYSE:AMPE) and Graybug Vision (NASDAQ:GRAY) Financial Contrast
- Ampio Pharmaceuticals Received Audit Opinion with Going Concern Explanation
- Ampio Announces Voluntary Delisting and SEC Deregistration
- 12 Health Care Stocks Moving In Thursday's Intraday Session
- Ampio Provides Update on Results from Pre-IND Enabling Studies
- Ampio Provides Litigation Update - Reports Settlement in Principle of Certain Pending Legal Actions
- Why LumiraDx Shares Are Trading Lower By Over 30%; Here Are 20 Stocks Moving Premarket
- 12 Health Care Stocks Moving In Friday's After-Market Session
Your note
Sign in to keep a note on AMPE — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BAR-OR DAVID | Director | Stock Award(Grant) | Jan 3, 2021 | 92,800 |
| BUCHI J KEVIN | Director | Purchase | Jun 8, 2023 | 146,858 |
| CHEREVKA HOLLI | Chief Operating Officer | Stock Award(Grant) | Oct 10, 2021 | 500,000 |
| COELHO PHILIP H | Director | Sale | May 20, 2021 | 203,500 |
| GILES RICHARD B | Director | Stock Award(Grant) | Jan 3, 2021 | 367,121 |
| MACALUSO MICHAEL | Chief Executive Officer | Stock Award(Grant) | Oct 10, 2021 | 2,736,750 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| HRT Financial LP | 0.69% | 5,202 | 24.24K | Jun 29, 2023 |
| Private Capital Management LLC | 0.32% | 2,397 | 11.17K | Jun 29, 2023 |
| Two Sigma Securities, LLC | 0.20% | 1,507 | 7.02K | Jun 29, 2023 |
| Renaissance Technologies, LLC | 0.19% | 1,425 | 6.64K | Jun 29, 2023 |
| Virtu Financial LLC | 0.17% | 1,265 | 5.89K | Jun 29, 2023 |
| Brighton Jones LLC | 0.16% | 1,230 | 5.73K | Jun 29, 2023 |